BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases

NCT07550088 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: Balstilimab (BAL)
DRUG: Botensilimab (BOT)
DRUG: agenT-797

Sponsor

Darren Sigal, MD

Collaborators

[object Object]